Described herein are pharmaceutical compositions comprising extended-release
pellets and optionally delayed release
pellets, wherein each of the extended-release
pellets and each of the delayed release pellets comprises a
drug pellet and an outer
coating; the outer
coating of the extended-release pellets is an extended-release outer
coating; the outer coating of the delayed release pellets is a delayed release outer coating; the outer coating of the extended-release pellets is an extended-release outer coating; the outer coating of the delayed release pellets is a delayed release outer coating; the
drug pellet comprises about 15 wt.% to about 25 wt.% ibudilast, about 60 wt.% to about 70 wt.%
sugar sphere, about 5 wt.% to about 10 wt.% hydroxypropyl methylcellulose, and about 4 wt.% to about 8 wt.%
silicon dioxide; the extended-release outer coating comprises about 20 wt.% to about 55 wt.%
ethyl cellulose, about 20 wt.% to about 55 wt.% hydroxypropyl methylcellulose, about 1 wt.% to about 4 wt.%
triethyl citrate, and about 20 wt.% to about 25 wt.%
talc, wherein the weight percentages of
ethyl cellulose, hydroxypropyl methylcellulose,
triethyl citrate, and
talc are based on total weight of the extended-release outer coating; and the delayed release outer coating comprises about 55 wt.% to about 65 wt.%
copolymer of
methacrylic acid and
ethyl acrylate, about 3 wt.% to about 9 wt.%
triethyl citrate, and about 25 wt.% to about 35 wt.%
talc, wherein the weight percentages of the
copolymer of
methacrylic acid and
ethyl acrylate, triethyl citrate, and talc are based on total weight of the delayed release outer coating.